Cardiovascular
Stent Thrombosis
0
Pipeline Programs↗
0
Active Trials↗
0
Companies Involved↗
Stent Thrombosis is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
4
clinical trials
Completed3 · 75%
Terminated1 · 25%
Clinical Trials
Trial Activity
TISSARA Trial: Ticagrelor Intervention to Reduce Stent Thrombosis and Acute MI Risk
Completed·National Institute of Cardiovascular Diseases, Pakistan·Phase 4·NCT06667349·1,727 enrolled
Association of Clopidogrel Therapy and Stent Thrombosis
Completed·—·Phase 4·NCT00484926·2,000 enrolled
Mechanism Of Stent Thrombosis (MOST) Study
Completed·—·Phase 4·NCT01410539·20 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)